Overriding sorafenib resistance via blocking lipid metabolism and Ras by sphingomyelin synthase 1 inhibition in hepatocellular carcinoma.
Lu H, Zhou L, Zuo H, Le W, Hu J, Zhang T, Li M, Yuan Y. Cancer Chemother Pharmacol. 2021 Feb; 87(2):217-228. Epub 2020 Nov 23.